Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute recently changed their screening criteria for potential donors for living donor kidney transplant. Now, prospective donors with hypertension, higher BMIs and a diagnosis of diabetes not on insulin can begin the donor evaluation process. As a result of this change, the program is currently on pace to do 120 living donor kidney transplants in 2025, a 100 percent increase from prior years.
“Studies have shown that the long-term risk for patients with these conditions is not significantly higher than patients without them. says Bernard Fischbach, MD, CCRP, medical director of kidney/pancreas transplantation at Baylor University Medical Center, part of Baylor Scott & White Health. “The changes in criteria have allowed us to consider more people for living donation while keeping donors safe and healthy.”
Each potential donor is evaluated by a team of transplant experts, including a transplant surgeon. Depending on the findings, potential donors may be referred for weight loss or diabetes management, allowing them to move forward in the evaluation process.
The BSW transplant team is also increasing access to living donor kidney transplants through ABO incompatible transplants and treating recipients with high antibody levels. The overall goal of the new approach is to determine how to facilitate a transplant if a patient has a willing potential donor rather than automatically ruling out the donor.
The BSW Simmons Transplant Institute team encourages patients with advanced chronic kidney disease to be proactive about finding a donor. Patients are encouraged to find someone to be their donor champion and to use social media and other communication avenues to let others know about their need and the opportunity for potential donation.
“We are gratified to see the positive impact these criteria changes have had on getting our patients transplanted more quickly,” Dr. Fischbach says. “We encourage our referring physicians to reach out to us with any questions or concerns about living kidney donation.”
Investigational stem cell infusion therapy shows promise in treating labile type 1 diabetes
A new treatment being tested at Baylor Dallas may help people with hard-to-control type 1 diabetes live without insulin and avoid dangerous low blood sugar episodes.
Liver transplant and sobriety saves a patient's life
After battling alcoholism and advanced liver disease, Kendon Greene found hope through Baylor Scott & White’s innovative Alcohol-Associated Liver Disease program—leading to a successful transplant and a renewed life of purpose.
Liver transplant volumes increase 30 percent year over year
Baylor University Medical Center achieved record-breaking liver transplant growth, driven by advanced technologies, living donor innovations, and expanded access for patients with alcohol-related liver disease.
Baylor Scott & White Simmons Transplant Institute shares experience and expertise at WTC
At the 2025 World Transplant Congress, Baylor Scott & White experts presented groundbreaking research in organ preservation, robotic surgery, and transplant innovation, reinforcing their leadership in the field.
Twice Blessed House offers patients convenient pre- and post-transplant housing
Experience comfort and convenience—Twice Blessed House provides transplant patients and caregivers with affordable, fully equipped housing just steps from their care team.